Company: DGLY
Filing Date: 2025-02-06
Form Type: S-1/A
Source: 0001493152-25-005144
Chunk: 5

Company: DIGITAL ALLY, INC.
Filing Date: 2025-02-06
Form: S-1/A
Chunk 5
---
 Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

The common stock and Pre-Funded Warrants, and the accompanying Warrants, as the case may be, can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance. Pursuant to the registration statement related to this prospectus, we are also registering the shares of common stock issuable upon exercise of the Warrants and Pre-Funded Warrants included in the Units and Pre-Funded Units offered hereby.

Our common stock is listed on The Nasdaq Capital Market under the symbol “DGLY.” The last reported sale price of our common stock on The Nasdaq Capital Market on February 3, 2025 was $0.188 per share. There is no established trading market for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants and we do not intend to list the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants on any securities exchange or nationally recognized trading system.

We have engaged Aegis Capital Corp. (“Aegis” or the “underwriter”) to act as our exclusive underwriter on a firm commitment basis in connection with this offering. We have agreed to pay to the underwriter the underwriting fees as set forth in the table below. We will bear all costs associated with the offering. See “ Underwriting” on page 98 of this prospectus for more information regarding these arrangements.

We have granted the underwriter an option to
purchase additional shares of common stock and/or Warrants of (i) up to 15% of the number of shares of common stock sold in the offering,
(ii) up to 15% of the number of Series A Warrants sold in the offering and (iii) up to 15% of the number of Series B Warrants sold in
the offering. The underwriter may exercise this option in whole or in part at any time within forty-five calendar days after the date
of this prospectus. The underwriter may exercise the over-allotment option with respect to shares of common stock only, Warrants only,
or any combination thereof. The purchase price to be paid per additional share of common stock will be equal to the public offering price
of one Unit (less $0.00001 allocated to each Warrant), as applicable, less the underwriting discount, and the purchase price to
be paid per